TELA Bio, Inc. (TELA)
0.8046
-0.02
(-1.89%)
USD |
NASDAQ |
Nov 16, 13:44
TELA Bio Profit Margin (Quarterly) : -49.06% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -49.06% |
| June 30, 2026 | -58.38% |
| March 31, 2026 | -64.39% |
| December 31, 2025 | -43.32% |
| September 30, 2025 | -41.58% |
| June 30, 2025 | -49.13% |
| March 31, 2025 | -60.82% |
| December 31, 2024 | -52.17% |
| September 30, 2024 | -54.71% |
| June 30, 2024 | -78.30% |
| March 31, 2024 | -34.10% |
| December 31, 2023 | -75.83% |
| September 30, 2023 | -72.79% |
| June 30, 2023 | -74.44% |
| March 31, 2023 | -101.0% |
| December 31, 2022 | -85.86% |
| September 30, 2022 | -96.01% |
| June 30, 2022 | -122.4% |
| Date | Value |
|---|---|
| March 31, 2022 | -132.0% |
| December 31, 2021 | -102.9% |
| September 30, 2021 | -108.0% |
| June 30, 2021 | -109.2% |
| March 31, 2021 | -138.4% |
| December 31, 2020 | -137.5% |
| September 30, 2020 | -145.0% |
| June 30, 2020 | -173.4% |
| March 31, 2020 | -193.8% |
| December 31, 2019 | -134.3% |
| September 30, 2019 | -117.4% |
| June 30, 2019 | -159.3% |
| March 31, 2019 | -180.5% |
| December 31, 2018 | -304.5% |
| September 30, 2018 | -126.9% |
| June 30, 2018 | -284.4% |
| March 31, 2018 | -320.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.07% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -2.47% |
| AtriCure, Inc. | 2.63% |
| Baxter International, Inc. | 10.01% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -64.88% |
| Return on Invested Capital | -90.36% |
| Gross Profit Margin (Quarterly) | 64.92% |
| Operating Margin (Quarterly) | -27.99% |
| Return on Net Operating Assets | -156.5% |